Monoclonal antibodies – the new kid on the block for managing OA

Ahead of his lecture on this topic at BSAVA Congress, Matt Gurney discusses his early experiences of using this treatment approach and explains how the role of nerve growth factor is an untapped pathway in the management of this disease…

Matt Gurney

Job Title

Share